Nilsine Partners’s Gilead Sciences GILD Stock Holding History

Nilsine Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Sell	16,624 -25	-0.2%	-$3.29K	0.15%	148
2026 Q1	$2.13M	Buy	16,649 +1,158	+7%	+$162K	0.17%	129
2025 Q4	$1.9M	Buy	15,491 +1,412	+10%	+$172K	0.16%	128
2025 Q3	$1.56M	Buy	14,079 +1,466	+12%	+$167K	0.14%	154
2025 Q2	$1.4M	Buy	12,613 +10,757	+580%	+$1.14M	0.14%	161
2025 Q1	$208K	Buy	+1,856	New	+$192K	0.02%	350
2024 Q2	–	Sell	-13,216	Closed	-$968K	–	330
2024 Q1	$968K	Buy	13,216 +790	+6%	+$60.7K	0.13%	174
2023 Q4	$1.01M	Buy	12,426 +532	+4%	+$41.4K	0.15%	164
2023 Q3	$891K	Buy	11,894 +127	+1%	+$9.77K	0.13%	173
2023 Q2	$907K	Buy	11,767 +30	+0.3%	+$2.39K	0.13%	175
2023 Q1	$974K	Buy	+11,737	New	+$972K	0.15%	167

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Nilsine Partners's GILD Position: Q2 2026 in Review

Nilsine Partners reduced its Gilead Sciences (GILD) stake by 0.15% in Q2 2026, selling an estimated $3.29K and leaving 16,624 shares worth $2.1M. The position accounts for 0.15% of the portfolio, ranked #148.

Nilsine Partners first reported a position in GILD in Q1 2023 and has held it in 11 quarters since. The position peaked at $2.13M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Nilsine Partners held 16,624 shares of Gilead Sciences worth $2.1M as of Q2 2026.
Nilsine Partners sold 25 Gilead Sciences shares in Q2 2026, an estimated $3.29K.
Gilead Sciences made up 0.15% of Nilsine Partners's portfolio in Q2 2026, its #148 holding.
Nilsine Partners first reported a position in Gilead Sciences in Q1 2023 and has held it in 11 quarters since.
Nilsine Partners's Gilead Sciences position peaked at $2.13M in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.